Journal ArticleDOI
Aging of Hepatitis C Virus (HCV)-Infected Persons in the United States: A Multiple Cohort Model of HCV Prevalence and Disease Progression
About:
This article is published in Yearbook of Gastroenterology.The article was published on 2010-01-01. It has received 584 citations till now. The article focuses on the topics: Hepatitis C virus.read more
Citations
More filters
Journal ArticleDOI
The Epidemiology of Cirrhosis in the United States: A Population-based Study.
Steven Scaglione,Stephanie Kliethermes,Guichan Cao,David A. Shoham,Ramon Durazo,Amy Luke,Michael L. Volk +6 more
TL;DR: The prevalence of cirrhosis in the general US population was higher than previously estimated, and more than half of cases may be undiagnosed and potentially preventable by controlling diabetes, alcohol abuse, and viral hepatitis.
Journal ArticleDOI
Epidemiology of hepatocellular carcinoma in the United States: Where are we? Where do we go?
Hashem B. El-Serag,Fasiha Kanwal +1 more
TL;DR: The age distribution of HCC patients has shifted to younger ages, with the greatest proportional increases among individuals 45-60 years old, and HCC incidence rates are reported to be higher among Hispanics born in the United States than among foreign-born Hispanics.
Journal ArticleDOI
Loco-regional treatment of hepatocellular carcinoma.
TL;DR: Novel thermal and nonthermal techniques for tumor ablation—including microwave ablation, irreversible electroporation, and light‐activated drug therapy—seem to have potential to overcome the limitations of radiofrequency ablation and warrant further clinical investigation.
Journal ArticleDOI
The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm.
A. Sibley,Kwang Hyub Han,A. Abourached,Laurentius A. Lesmana,Mihály Makara,Wasim Jafri,Riina Salupere,Abdullah M. Assiri,Adrian Goldis,Faisal Abaalkhail,Zaigham Abbas,A. Abdou,F. Al Braiki,F. Al Hosani,K. Al Jaberi,M. Al Khatry,M. A. Al Mulla,H. Al Quraishi,A. Al Rifai,Y. Al Serkal,Altaf Alam,Seyed Moayed Alavian,Hamad I. Al-Ashgar,S. Alawadhi,L. Al-Dabal,P. Aldins,Faleh Z. Al-Faleh,Abdullah S. Alghamdi,R. Al-Hakeem,Abdulrahman Aljumah,A. Almessabi,Adel Alqutub,Khalid Alswat,Ibrahim Altraif,M. Alzaabi,N. Andrea,Mohamed A. Babatin,A. Baqir,M. T. Barakat,Ottar M. Bergmann,Abdul Rahman Bizri,Sarah Blach,Asad Chaudhry,M. S. Choi,T. Diab,Samsuridjal Djauzi,E. S. El Hassan,S. El Khoury,Chris Estes,S. Fakhry,J. I. Farooqi,J. I. Farooqi,H. Fridjonsdottir,Rino Alvani Gani,A. Ghafoor Khan,Liana Gheorghe,Magnus Gottfredsson,S. Gregorcic,Jessie Gunter,Behzad Hajarizadeh,Behzad Hajarizadeh,Saeed Hamid,Irsan Hasan,Almoutaz Hashim,Gabor Horvath,Béla Hunyady,R. Husni,Agita Jeruma,Jon G. Jonasson,Jon G. Jonasson,B. Karlsdottir,Do Young Kim,Young Seok Kim,Z. Koutoubi,Valentina Liakina,Valentina Liakina,Young-Suk Lim,A. Löve,A. Löve,Matti Maimets,Reza Malekzadeh,Mojca Maticic,Muhammad S. Memon,Shahin Merat,Jacques E Mokhbat,Fadi H. Mourad,David H. Muljono,David H. Muljono,Arif Nawaz,N. Nugrahini,S. Olafsson,S. Priohutomo,H. Qureshi,P. Rassam,Homie Razavi,Devin Razavi-Shearer,Kathryn Razavi-Shearer,Baiba Rozentale,M. Sadik,K. Saeed,A. Salamat,Faisal M. Sanai,A. Sanityoso Sulaiman,R. A. Sayegh,Ala I. Sharara,M. Siddiq,A. M. Siddiqui,G. Sigmundsdottir,B. Sigurdardottir,Danute Speiciene,Andri Sanityoso Sulaiman,Marwa Sultan,M. Taha,Junko Tanaka,H. Tarifi,G. Tayyab,Ieva Tolmane,M. Ud Din,M. Umar,M. Umar,M. Umar,Jonas Valantinas,J. Videčnik-Zorman,Cesar Yaghi,Evy Yunihastuti,M. A. Yusuf,Bader Faiyaz Zuberi,Jonathan Schmelzer +127 more
TL;DR: The current treatment rate and efficacy are not sufficient to manage the disease burden of hepatitis C virus and alternative strategies are required to keep the number of HCV individuals with advanced liver disease and liver‐related deaths from increasing.
Journal ArticleDOI
Chronic Hepatitis C Infection
TL;DR: This article reviews the evaluation and initial management of chronic hepatitis C infection, with particular attention to the use of new directly acting antiviral agents in treatment regimens.
References
More filters
Journal ArticleDOI
Aging of Hepatitis C Virus (HCV)-Infected Persons in the United States: A Multiple Cohort Model of HCV Prevalence and Disease Progression
TL;DR: Prevalence of hepatitis C cirrhosis and its complications will continue to increase through the next decade and will mostly affect those older than 60 years of age, but wider application of antiviral treatment and better responses with new agents could significantly reduce the impact of this disease in coming years.
Related Papers (5)
The Epidemiology of Chronic Hepatitis C and One-Time Hepatitis C Virus Testing of Persons Born During 1945 to 1965 in the United States
Co-infection by hepatitis C virus in HIV-infected patients in southern Brazil: genotype distribution and clinical correlates.
Fernando Herz Wolff,Fernando Herz Wolff,Sandra Cristina Pereira Costa Fuchs,Sandra Cristina Pereira Costa Fuchs,Nêmora Tregnago Barcellos,Nêmora Tregnago Barcellos,Paulo Ricardo de Alencastro,Maria Letícia Rodrigues Ikeda,Ajácio Bandeira de Mello Brandão,Ajácio Bandeira de Mello Brandão,Maicon Falavigna,Flávio Danni Fuchs +11 more
Human immunodeficiency virus/hepatits C virus coinfection in Spain: elimination Is feasible, but the burden of residual cirrhosis will be significant
Juan Berenguer,Inmaculada Jarrín,Leire Pérez-Latorre,Víctor Hontañón,María J. Vivancos,Jordi Navarro,María Jesús Téllez,Josep M. Guardiola,José Antonio Iribarren,Antonio Rivero-Juárez,Manuel Márquez,Arturo Artero,Luis Morano,Ignacio Santos,J. Moreno,M.C. Fariñas,María José Galindo,María Nieves Aja Hernando,Marta Montero,Carmen Cifuentes,Pere Domingo,José Sanz,Lourdes Domíngez,Oscar Ferrero,Belén de la Fuente,Carmen Rodríguez,Sergio Reus,José Hernández-Quero,Gabriel Gaspar,Laura Pérez-Martínez,Coral García,Lluís Force,S. Veloso,Juan Emilio Losa,Josep Vilaró,Enrique Bernal,Sari Arponen,Amat Ortí,Ángel Chocarro,Ramón Teira,Gerardo Alonso,Rafael Silvariño,Ana Vegas,Paloma Geijo,Josep Bisbe,Herminia Esteban,Juan González-García +46 more